Amgen Sues Roche Over Anemia Treatment
Amgen is seeking a declaratory judgment of infringement by Switzerland-based Roche, as well as its subsidiaries F. Hoffmann-LaRoche Ltd., Roche Diagnostics GmbH and Hoffmann-LaRoche Inc. It was filed in the U.S. District Court for the District of Massachusetts.
The treatment in the case, Epogen, is a recombinant version of...
To view the full article, register now.